Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPSOUSA, Rafael T. deBUSNELLO, Joao V.FORLENZA, Orestes V.ZANETTI, Marcus V.SOEIRO-DE-SOUZA, Marcio G.BILT, Martinus T. van deMORENO, Ricardo A.ZARATE JR., Carlos A.GATTAZ, Wagner F.MACHADO-VIEIRA, Rodrigo2013-07-302013-07-302012JOURNAL OF PSYCHIATRIC RESEARCH, v.46, n.12, p.1564-1568, 20120022-3956https://observatorio.fm.usp.br/handle/OPI/1108Although lithium has been the first line agent in the treatment of bipolar disorder (BD), few studies have evaluated lithium's efficacy in mania with psychosis and its association with later response. Furthermore, given the widespread concern about antipsychotic side effects, answering a question about whether lithium alone can manage to treat both psychotic and non-psychotic mania seems a very relevant one. The present study addresses the antipsychotic efficacy of lithium monotherapy in acute mania and early improvement of psychotic symptoms as a predictor of later response of manic symptoms. Forty-six patients presenting a manic episode (32 with psychotic features and 14 subjects without psychotic features) were treated for 4 weeks with lithium monotherapy and evaluated weekly using the Young Mania Rating Scale (YMRS). Subjects with rapid cycling, substance abuse/dependence, or mixed episodes were excluded. The overall antimanic efficacy of lithium in psychosis vs. non-psychosis groups was evaluated. In addition, early improvement of psychotic symptoms and its prediction of subsequent response (>50% decrease in total YMRS scores) or remission were evaluated. Lithium showed a similar efficacy in both psychosis and non-psychosis mania. Early improvement of psychotic symptoms was associated with clinical response and remission at endpoint.engrestrictedAccessPsychosisManiaLithiumEarly improvementMonotherapybipolar disorderdouble-blindplaceboefficacyrecommendationsantipsychoticsschizophreniaspecificityguidelinesillnessEarly improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in maniaarticleCopyright PERGAMON-ELSEVIER SCIENCE LTD10.1016/j.jpsychires.2012.08.011Psychiatry